← Open Payments lookup

NATALIE CHASTANT: Open Payments

NPI 1669702403 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,615 in 63 payments from 27 companies in 2025. Trend: 2023 $1,207 · 2024 $1,725 · 2025 $2,615

Food & beverage: $1,317Long term medical supply or device loan: $1,196Education: $101
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation15$1,285
Janssen Biotech, Inc.6$303
Stemline Therapeutics Inc.4$146
Daiichi Sankyo Inc.4$127
Lilly USA, LLC3$127
GlaxoSmithKline, LLC.6$94
Geron Corporation2$47
Merck Sharp & Dohme LLC2$46
PFIZER INC.2$46
Gilead Sciences, Inc.2$39

Products named: KISQALI, RYBREVANT, ELZONRIS, Enhertu, Fabhalta, JEMPERLI, RYTELO, OJJAARA.

Industry payments across TX — which companies pay providers there.